SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 106.26-0.4%2:17 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Carragher who wrote (972)7/28/1998 7:26:00 AM
From: John Carragher  Read Replies (1) of 1580
 
Merck In 5-Yr Pact To Buy Methyldopa
From Hungary's Egis Rt.

BUDAPEST -- U.S. drug maker Merck & Co. (MRK) signed an
agreement Tuesday to buy methyldopa, an ingredient used in the treatment
of hypertension, from Hungarian pharmaceuticals maker Egis Rt. (R.EGS)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News